Literature DB >> 12829203

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.

David M Mannino1, Earl S Ford, Stephen C Redd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12829203     DOI： 10.1016/s0002-9343(03)00185-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  94 in total

1.  C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.

Authors:  Funda Aksu; Nermin Capan; Kurtuluş Aksu; Ruhsar Ofluoğlu; Sema Canbakan; Bünyamin Yavuz; Kadir Okhan Akin
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).

Authors:  Xia Wei; Qi Ding; Nan Yu; Jiuyun Mi; Jingting Ren; Jie Li; Shudi Xu; Yanzhong Gao; Youmin Guo
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

Review 3.  Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Omar A Minai; Zab Mosenifar
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 4.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

5.  Predictors of cardiopulmonary hospitalization in chronic spinal cord injury.

Authors:  Anthony C Waddimba; Nitin B Jain; Kelly Stolzmann; David R Gagnon; James F Burgess; Lewis E Kazis; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

6.  Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.

Authors:  Y Kubota; S J London; M Cushman; A M Chamberlain; W D Rosamond; S R Heckbert; N Zakai; A R Folsom
Journal:  J Thromb Haemost       Date:  2016-11-08       Impact factor: 5.824

7.  Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Authors:  Francisco Garcia-Rio; Marc Miravitlles; Joan B Soriano; Luis Muñoz; Enric Duran-Tauleria; Guadalupe Sánchez; Víctor Sobradillo; Julio Ancochea
Journal:  Respir Res       Date:  2010-05-25

Review 8.  Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.

Authors:  Ruzena Tkacova
Journal:  Mediators Inflamm       Date:  2010-04-20       Impact factor: 4.711

9.  Systemic inflammation in young adults is associated with abnormal lung function in middle age.

Authors:  Ravi Kalhan; Betty T Tran; Laura A Colangelo; Sharon R Rosenberg; Kiang Liu; Bharat Thyagarajan; David R Jacobs; Lewis J Smith
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Proinflammatory cytokines in Egyptian elderly with chronic obstructive pulmonary disease.

Authors:  Moatassem S Amer; Hoda M F Wahba; Samiha S A Ashmawi; Randa Reda Mabrouk; Ahmad A E Sharaf Eldeen; Sarah A Hamza
Journal:  Lung India       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.